Semiology, proteomics, and the early detection of symptomatic cancer (Q47610474)

4 February 2018

title

Semiology, proteomics, and the early detection of symptomatic cancer (English)

1 reference

4 February 2018

author

Esteve Fernández

series ordinal

2

1 reference

4 February 2018

author name string

Miquel Porta

series ordinal

1

1 reference

4 February 2018

Joan Alguacil

series ordinal

3

1 reference

4 February 2018

publication date

1 September 2003

1 reference

4 February 2018

Journal of Clinical Epidemiology

published in

1 reference

4 February 2018

volume

56

1 reference

4 February 2018

issue

9

1 reference

4 February 2018

page(s)

815-819

1 reference

4 February 2018

Relationship between delayed diagnosis and the degree of invasion and survival in lung cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Symptom-to-diagnosis interval and survival in cancers of the digestive tract

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Emergency admission for cancer: a matter of survival?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Cancer survival and the duration of symptoms. An analysis of possible forms of the risk function

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Influence of "diagnostic delay" upon cancer survival: an analysis of five tumour sites

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Symptoms as an Index of Biological Behaviour and Prognosis in Human Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

The auxometric dimension. A new method for using rate of growth in prognostic staging of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Cancer of the larynx: a new staging system and a re-appraisal of prognosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

A new clinical index of growth rate in the staging of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Prognostic staging system for recurrent, persistent, and second primary cancers of the oral cavity and oropharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Is "quality of care" being mislabeled or mismeasured?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Waiting times for outpatient appointments

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

The differential diagnosis of primary lung cancer: inter-observer agreement and contribution of specific diagnostic procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Trends in cardiovascular mortality and the quality of vital statistics

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Cancer staging may have different meanings in academic and community hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Factors associated with speed of diagnosis, referral, and treatment in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Colorectal carcinoma: do elderly patients present differently?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Recognition and evaluation of oncology-related symptoms in the emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Do we believe what patients say about their neoplastic symptoms? An analysis of factors that influence the interviewer's judgement.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Radiolabelled monoclonal antibodies in tumour imaging and therapy: out of fashion?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Screening for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Prospects for lung-cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Use of proteomic patterns in serum to identify ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Medical applications of microarray technologies: a regulatory science perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Proteomic applications for the early detection of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Proteomic patterns in serum and identification of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Clinical epidemiological quality in molecular genetic research: the need for methodological standards

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Misguided efforts and future challenges for research on "diagnostic tests"

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Basic biomedical science and the destruction of the pathophysiologic bridge from bench to bedside

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Racial differences in the treatment of early-stage lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Lung cancer: district active treatment rates affect survival

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Who gets chemotherapy for metastatic lung cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Social factors, treatment, and survival in early-stage non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

Mutations, tissue accumulations, and serum levels of p53 in patients with occupational cancers from asbestos and silica exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2803%2900165-3

7 January 2021

10.1016/S0895-4356(03)00165-3

Identifiers

DOI

1 reference

4 February 2018

release_fzepzno7zraahbudt44bzcfqrm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fzepzno7zraahbudt44bzcfqrm

24 November 2022

mapped directly with Wikidata item

1 reference

4 February 2018